TGA / PMDA / NMPA · Asia-Pacific
vaccination — TGA / PMDA / NMPA regulatory status
vaccination regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.
Status snapshot
- Status
- NMPA clinical trials
- Structured fields
- 4
Regional decision snapshot — NMPA: clinical trials.
Linked evidence on this spoke: 18 published clinical programs and 12 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.
Regulatory timeline
| Regulator | Region | Status | Date | Source |
|---|---|---|---|---|
| NMPA | China | clinical trials | — | Evidence |
Linked clinical programs
| Program | Phase | Sponsor | NCT |
|---|---|---|---|
| Flublok Quadrivalent vaccine | Phase 3 | Hospital Authority | NCT05479370 |
| sIPV-bOPV-bOPV vaccination schedule | Phase 3 | Sinovac Research and | NCT03822754 |
| sIPV-sIPV-bOPV vaccination schedule | Phase 3 | Sinovac Research and | NCT03822767 |
| Dendritic Cell Vaccination | Phase 2 | Quantum Pharmaceuticals | NCT00879489 |
| BNT164-01 | Phase 1 | BioNTech SE | 2023-509515-89-00 |
| Dendritic Cell Vaccination | Phase 1 | Quantum Pharmaceuticals | NCT00715832 |
| Evaluation of the Novel Therapeutic Hepatitis... for chronic Hepatitis B | Phase 1 | Disc Medicine | 2024-518355-36-01 |
| 23-valent pneumococcal polysaccharide vaccine | Approved | Chinese Academy of | NCT04700618 |
| 60 µg dose hepatitis B vaccine | Approved | Chinese Academy of | NCT02959775 |
| Gardasil 9 suspension for Evaluation of the reduction of… | Approved | George Institute for | 2024-515228-36-00 |
| Hepatitis B vaccine | Approved | Chia Tai Tianqing | NCT03212911 |
| Inactivated Polio Vaccine | Approved | Chinese Academy of | NCT04051736 |
Related patents
| Number | Title | Jurisdiction |
|---|---|---|
| 2026013161 | VACCINATION DE PREMIÈRE IMMUNISATION ET DE RAPPEL POUR LE TRAITEMENT ET LA PRÉVENTION D'INFECTIONS PROVOQUÉES PAR LE VIRUS DE LA GRIPPE AVIAIRE CHEZ LES AVIENS | WO |
| 2025238220 | ACIDES NUCLÉIQUES POUR LA VACCINATION CODANT POUR DES NANOPARTICULES DE PROTÉINE DE PRÉSENTATION DES ANTIGÈNES | WO |
| 2025281584 | ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS | US |
| 11918642 | HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting HIV antigens | US |
| 3255048 | COMPOSITION IMMUNOGÈNE UTILE POUR LA VACCINATION CONTRE LES ROTAVIRUS | CA |
| 11096996 | Cancer vaccines and vaccination methods | US |
| 11071778 | Combination product for use in tumor vaccination | US |
| 11052144 | Methods of tumor vaccination | US |
| 11007261 | Compositions and methods of vaccination against dengue virus in children and young adults | US |
| 10925946 | Vaccination methods | US |
| 10376574 | Compositions and methods for vaccination against influenza A virus | US |
| 10363292 | Vaccination with anti-tick antigens to control multiple tick species and disease transmission in white-tailed deer and other host animals | US |
Related hubs
FAQ
What is the TGA / PMDA / NMPA approval status of vaccination?
vaccination currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.
Where does NovaPharmaNews get vaccination regulatory data?
Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.
How many clinical programs are linked to vaccination?
This spoke lists 18 published programs associated with vaccination in our pipeline index.